Tayra.ai has successfully closed its pre-seed funding round

Our product, Tayra.ai, has successfully closed its pre-seed funding round and entered into a strategic partnership with a major global pharmaceutical company.

For the WINSTARS.AI team, this milestone is especially meaningful. We invested in Tayra.ai at an early stage and became a trusted technology partner, supporting its journey from initial development and testing to a fully fledged AI solution.

Tayra.ai streamlines interactions between doctors, patients, and medical information systems, reducing administrative workload and giving doctors more time to focus on patient care. Today, the platform is available to more than 6,500 doctors and integrated with five medical information systems in Ukraine, with two more integrations in their final stages.

For us, this is further proof that technologies developed in Ukraine are already addressing real challenges in the global healthcare industry.

We are proud to be part of this journey and the broader transformation of healthcare.